- Generic name
- Erythropoietin
- Strength
- 10000 IU/ml
- Dosage form
- Injection
- Manufactured by
- Incepta Pharmaceuticals Ltd.
Epoetin Injection
About Epoetin 10000 IU/ml Injection
Epoetin is a injection from Incepta Pharmaceuticals Ltd., with the generic name Erythropoietin. Epoetin is used to treat anemia associated with chronic renal failure, both in patients who are on dialysis and in those who are not.
There are 8 brands of Erythropoietin listed in Bangladesh.
What is Epoetin 10000 IU/ml Injection?
Epoetin 10000 IU/ml injection is a medicine made by Incepta Pharmaceuticals Ltd. Epoetin injection contains Erythropoietin, a protein that works like a natural hormone the body makes to stimulate red blood cell production. It belongs to a group of drugs used for haemolytic, hypoplastic and renal anaemia. The doctor decides the dose, the route and how often it is given, and monitors the response with blood tests over time.
Uses of Epoetin
Epoetin is used to treat anemia associated with chronic renal failure, both in patients who are on dialysis and in those who are not. It is also used for anaemia in some patients with non-myeloid cancers where the anaemia is caused by chemotherapy given alongside. It is not a general tonic for tiredness, and it should only be used when a doctor has confirmed that it fits the patient's condition. Ask your doctor whether it is right for your condition.
How to use Epoetin
Epoetin is given as an injection by a doctor or a trained health worker, either into a vein or under the skin, depending on the doctor's plan. Epoetin is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how. Do not crush or chew the injection. Complete the course exactly as prescribed. The doctor decides the dose, how often it is given, and how long treatment continues, based on blood tests and the patient's response.
Side effects of Epoetin
Headache, dizziness, fever, tiredness and joint pain have been reported, and occasionally raised potassium levels. Raised blood pressure is the most common side effect, and palpitations can occur. Like other medicines, Epoetin can cause side effects. Contact your doctor if you notice anything unusual after taking it. Tell your doctor promptly about severe or persistent symptoms, and seek urgent help if you have signs of a serious allergic reaction, such as swelling or difficulty breathing.
Safety and precautions
Epoetin is not for people with uncontrolled high blood pressure, or with a known allergy to mammalian cell-derived products or to Erythropoietin or any ingredient of the preparation. Epoetin is not suitable for everyone. In pregnancy it is classified as Category C, so it should be used only if clearly needed; it is not known whether it passes into breast milk, so breastfeeding mothers should ask their doctor first. Tell your doctor about all your conditions and medicines first.
Frequently asked questions
Why is Epoetin prescribed?
Epoetin is used to treat anemia associated with chronic renal failure, both in patients who are on dialysis and in those who are not. It is also used for anaemia in some patients with non-myeloid cancers where the anaemia is caused by chemotherapy given alongside.
How should I take Epoetin?
Epoetin is given as an injection by a doctor or a trained health worker, either into a vein or under the skin, depending on the doctor's plan. Epoetin is given as an injection by a healthcare professional.
Can Epoetin cause side effects?
Headache, dizziness, fever, tiredness and joint pain have been reported, and occasionally raised potassium levels. Raised blood pressure is the most common side effect, and palpitations can occur.
Can I use Epoetin in pregnancy or while breastfeeding?
Epoetin is not for people with uncontrolled high blood pressure, or with a known allergy to mammalian cell-derived products or to Erythropoietin or any ingredient of the preparation. Epoetin is not suitable for everyone.
Indications
- Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
- Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy. ... Read more
- Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
- Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
- Anemic patients (hemoglobin >10 to <13 g/dL) are scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions.
- Anemia related to therapy with zidovudine in HIV-infected patients.
Dosage & Administration
Starting dose:
- Adult: Usually 50 to 100 lU/kg three times in a week (TIW) by IV or Subcutaneous route.
- Pediatric: 50 lU/kg TIW by IV or Subcutaneous route.
Maintenance dose: Maintenance dose must be individualized for each patient. In patients undergoing dialysis, the median maintenance dose is 75 lU/kg TIW, with a range from 12.5 to 525 lU/kg TIW as directed by the physician. In CRF patients not on dialysis, maintenance dose is 75 to 150 lU/kg/week.
Treatment of Anemia in Cancer Patients on Chemotherapy:
Starting dose:
- Adult: 150 lU/kg TIW by Subcutaneous route or 40,000 IU Subcutaneous route weekly.
- Pediatric: 25 to 300 lU/kg 3 to 7 times per week by Subcutaneous or IV route.
Surgery Patients: The recommended dose is 300 lU/kg/day subcutaneously for 10 days before surgery, on the day of surgery, and for 4 days after surgery. An alternate dose schedule is 600 lU/kg subcutaneously in once weekly dose (21, 14, and 7 days before surgery) plus a fourth dose on the day of surgery.
Zidovudine-treated HIV-infected Patients:
Starting dose
- Adult: 100 lU/kg as an IV or Subcutaneous injection TIW for 8 weeks.
- Pediatric: 50 to 400 lU/kg 2 to 3 times per week by Subcutaneous or IV route.
Maintenance dose: The dose is titrated to maintain the hematocrit between 33-36%.
Contraindications
- Uncontrolled hypertension
- Known hypersensitivity to mammalian cell-derived products
- A history of hypersensitivity to Erythropoietin or any component of the preparation.
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Iron evaluation: Prior to and during Erythropoietin therapy, the patient's iron stores, including transferrin saturation and serum ferritin, should be evaluated. Transferrin saturation should be at least 20%, and ferritin should be at least 100 ng/ml. Virtually all patients will require supplemental Iron to increase or maintain transferrin saturation to levels that will adequately support erythropoiesis.
Overdose Effects
Storage Conditions
Alternative brands of Erythropoietin
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.